Innovation Partnerships at the University of Michigan
Venture capitalAnn Arbor · Seed–Series A · 3 people tracked
Investment thesis
Michigan Biomedical Venture Fund is an investment vehicle affiliated with the University of Michigan that provides funding to early-stage companies developing therapeutics, medical devices, diagnostics, or health IT applications based on university-licensed intellectual property. The fund focuses exclusively on biomedical startups originating from U-M technology.
Team · 3 people
from public directoriesFrequently asked questions
- What stage does Innovation Partnerships at the University of Michigan invest at?
- Innovation Partnerships at the University of Michigan invests at the Seed, Series A stages.
- What is Innovation Partnerships at the University of Michigan's typical check size?
- Innovation Partnerships at the University of Michigan typically writes checks of $100K – $300K.
- What sectors does Innovation Partnerships at the University of Michigan focus on?
- Innovation Partnerships at the University of Michigan focuses on Biotech, Fintech, Healthtech, Medical Devices, Mobility & Transportation, SaaS.
- Where is Innovation Partnerships at the University of Michigan located?
- Innovation Partnerships at the University of Michigan is headquartered in Ann Arbor, US.
Similar investors
.jpeg){kind=logo}
B Capital is a global investment firm backing early to late-stage technology innovators across technology, healthcare, and energy & resilience sectors.
Khosla Ventures is a venture capital firm founded by Vinod Khosla.
The Alibaba Entrepreneurs Fund is a not-for-profit initiative of Alibaba Group that provides investment capital and strategic guidance to entrepreneurs and young people, focusing on Hong Kong and Taiwan-nexus startups.
K3 Ventures presents itself as an investment platform focused on collaboration and partnership between founders and stakeholders, emphasizing trust, relevance, and long-term support.
Taiwania Capital is a venture capital firm investing across technology and life science sectors, backing companies in Taiwan, Europe, and globally.